Highlights:
Good progress in the second year of our 14 Cubed growth plan
Revenue up 4.8% on an organic constant currency basis; total revenues up 4.0% to £350.8 million (2012: £337.3 million)
Adjusted profit before tax* up 14.8% to £48.2 million (2012: £42.0 million)
Adjusted operating profit* margin increased to 14.2% (2012: 12.5%)
Adjusted EPS* up 10.9% to 68.3 pence (2012: 61.6 pence)
On a constant currency basis, Nanotechnology Tools organic sales up 9.4%
Industrial markets remained soft
Strong progress in emerging and fast growing economies
Asylum Research acquisition integrating well and performing to plan
Strong new product pipeline supported by increased investment in R&D, up 5.9% to £25.1 million (2012: £23.7 million)
Net cash from operating activities of £41.5 million (2012: £41.6 million)
Proposed final dividend increased by 12.8% to 8.15 pence (2012: 7.23 pence), giving a total dividend for the year of 11.2 pence (2012: 10.0 pence)
Jonathan Flint, Chief Executive of Oxford Instruments plc, said:
"I am pleased to report that the Group has delivered another strong performance in the year. We are now two months into the final year of the three year period covered by the 14 Cubed objectives. Although the year has started slowly, we are focused on completing our 14 Cubed plan and delivering further progress in the years to come. Our R&D plan continues to deliver new products to the market which take market share from our competitors. We are building on our strong position in emerging and fast growing economies and we continue to target growth, both organically and through bolt-on acquisitions."
